ArticleOncoTargets and therapy2017

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.

Vanessa Meier-Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.